D. E. Shaw & Co., Inc. Crispr Therapeutics Ag Put Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$44.62 - $62.75 $1.07 Million - $1.51 Million	24,000 Added 208.7%	35,500 $1.67 Million
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $81,872 - $109,088	-1,600 Reduced 12.21%	11,500 $621,000
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $4.44 Million - $6.52 Million	-73,200 Reduced 84.82%	13,100 $892,000
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $2.95 Million - $5.51 Million	76,300 Added 763.0%	86,300 $5.4 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $869,400 - $1.36 Million	-20,000 Reduced 66.67%	10,000 $561,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $2.87 Million - $3.93 Million	-70,000 Reduced 70.0%	30,000 $1.36 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $1.57 Million - $2.63 Million	40,000 Added 66.67%	100,000 $4.07 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $1.83 Million - $2.51 Million	-30,000 Reduced 33.33%	60,000 $3.92 Million
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $1.73 Million - $2.95 Million	-40,000 Reduced 30.77%	90,000 $5.47 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $3.19 Million - $4.75 Million	60,000 Added 85.71%	130,000 $8.16 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $3.93 Million - $6.23 Million	56,000 Added 400.0%	70,000 $5.31 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $5.51 Million - $7.83 Million	-50,000 Reduced 78.13%	14,000 $1.57 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $6.2 Million - $9.96 Million	-61,500 Reduced 49.0%	64,000 $10.4 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $11.7 Million - $22.2 Million	105,500 Added 527.5%	125,500 $15.3 Million
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $385,000 - $760,500	-10,000 Reduced 33.33%	20,000 $1.47 Million
Q4 2018 Feb 14, 2019	BUY	$22.73 - $42.34 $681,900 - $1.27 Million	30,000 New	30,000 $857,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$367 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$347 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$139 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$137 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$137 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account